Latest filing published 12 Aug 2026 for Vir Biotechnology, Inc.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
This profile gathers the share dealings of Robert J. More across 2 companies, led by Vir Biotechnology, Inc. and Tyra Biosciences, Inc. Between 20 May 2021 and 11 August 2026, the trades on record add up to 19 filings.
Sales make up the whole of the open-market record (7 sales, €6.0M). The rest of the record consists of 6 share grants.
The record was last updated on 12 August 2026 with a transaction in Vir Biotechnology, Inc. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
19 of 19 declarations